Divestiture of all legacy services and intervention operations completed, resulting in a 100% pure-play cloud-based SaaS and DaaS platform provider...
Divestiture of all legacy services and intervention operations completed, resulting in a 100% pure-play cloud-based SaaS and DaaS platform provider...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Biofourmis, a leading global technology-enabled care delivery company, and AdventHealth, have agreed to collaborate on a continuum-wide remote...
DENVER, CO / ACCESSWIRE / January 6, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company...
EXTON, PA / ACCESSWIRE / January 6, 2025 / Frontage Holdings Corporation today announced that Dr. Abdul Mutlib has decided...
dicentra congratulates SterileCare on achieving a significant milestone in their innovative catheter lock solution clinical trial, with 20 patients enrolled...
Celebrating excellence in ENT care with recognized physicians in New Jersey and Philadelphia. PRINCETON, NEW JERSEY / ACCESSWIRE / January...
BEIJING, CHINA / ACCESSWIRE / January 6, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI), a biopharmaceutical company specializing in the development...
Accomplished Commercialization Leader to Drive Global Growth.Proven Expertise in Scaling Health Tech Businesses - Mr. Kendall Brings a Track Record...
CARMEL, Ind., Jan. 06, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology...
CAMBRIDGE, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading gene editing company, today announced...
VR app features Nova, the new embodied AI companion that sparks conversation and adventure from the comfort of the homeBOSTON,...
– Approximately $10 million additional investment in private placement equity financing – – $1.5 million from CIRM grant first announced...
IRVINE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused...
Document Updated for the First Time Since 2017Arlington, Virginia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Whether a material is compatible...
SEATTLE and VANCOUVER, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical...
Highly Positive Clinical Data on Completion of Testing for First Subject Dosed Twice Daily with QRX003 in Open-Label StudyDemonstrated Clinical...
• PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indications • NAYA aiming...
Secures New Debt Financing of up to $125M Maturing in 2030 with Plans to Retire $200M in Prior Debt Reports Unaudited...
JUPITER, Fla., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI),...